Smart Adv
Diabetic Kidney Disease - Clinical Study [US,CA] (Email,Social,Banner,Native,Push,SEO,Search,Brand Bidding) - CPL
DESCRIPTION
Conversion Point: Valid Form Fill Age Range: 30-80 Gender: All GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Fo ...
RESTRICTIONS
Conversion Point: Valid Form Fill Age Range: 30-80 Gender: All GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Qualifications: Diagnosed with Type 2 Diabetes Cannot be receiving dialysis Cannot have a history of heart or liver failure Cannot be on blood thinners Diabetic kidney disease (diabetic nephropathy) is a common complication of type 1 and type 2 diabetes. Over time, poorly controlled diabetes can cause damage to blood vessel clusters in your kidneys that filter waste from your blood. This can lead to kidney damage and cause high blood pressure. Study Description: The purpose of this clinical study is to see how effective an investigational injectable cell therapy is at helping to treat diabetic kidney disease. You may be asked to attend a screening visit to determine if you are eligible to enroll in the study. If enrolled, you will be randomly assigned to one of two groups. One group will undergo a kidney biopsy. The study team will prepare the investigational product from the biopsy tissue. You will then receive one injection of your own highly concentrated kidney cells into each kidney, three months apart. The second group will undergo simulated procedures for the biopsy and the injections, meaning that the procedure will be mimicked, but no actual tissue is extracted and reinjected. You will not know which group you are in while participating in the study. Your total participation may last up to 5 years. You will be asked to attend 16 office visits in the first 6 months and then follow-up visits every 3 months until the study ends. During these visits, you will complete various procedures, diagnostic and laboratory tests. The doctor’s office conducting the study will be able to provide you with more information about the study requirements.